Low-dose clot-busting medicine with emergency angioplasty for heart attacks
Part of Heart & circulation clinical trials.
This trial tests whether adding a low dose of a clot-busting medicine to the standard emergency procedure to open blocked heart arteries can improve outcomes for people having a heart attack. It aims to see if the combination is safe and more effective than the standard procedure alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are aged between 18 and 75 years.
- You are having a type of heart attack called STEMI, with symptoms that started within the last 12 hours.
- Your doctor has confirmed you have a large clot in the heart artery.
- You are willing to receive an investigational treatment and sign a consent form.
- You are not pregnant or breastfeeding, and you do not have other serious health conditions that might make participation unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to treat a major heart attack: using a drug-coated balloon or a drug-eluting stent. If you are having a heart attack and need emergency angioplasty, you may qualify if your artery blockages meet specific size limits and you have no bleeding risks or allergies to the medicines used.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
This trial tests whether a half-dose medicine called r-SAK given before a primary PCI heart stent procedure improves outcomes and safety in people with a specific type of heart attack. It may help the heart recover better, but it also checks the risk of side effects like bleeding.
This study tests different ways of restoring blood flow for people having a heart attack (STEMI) when the usual emergency procedure (primary PCI) may be delayed. It aims to see if giving a clot-busting medicine beforehand is as good as waiting for the procedure, or if another approach works better.
This trial tests a new way to treat heart attacks by using a special balloon to deliver medication to the heart's small blood vessels during a standard stenting procedure. It may help reduce damage to the heart muscle after a heart attack.
This trial tests a new approach to treating blood clots during a heart attack to prevent damage to the small blood vessels in your heart. You would receive this treatment during an emergency catheterization procedure if you have signs of a major heart attack.
Hear when a new ST Elevation Myocardial Infarction (STEMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.